(ethylenedinitrilo)-tetramethylenephosphonic acid has been researched along with Ache in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayouth, JE; Fossella, FV; Kasi, LP; Macey, DJ | 1 |
| Fordyce, WA; Fossella, FV; Goeckeler, WF; Kasi, LP; Price, DR; Stoneburner, LK | 1 |
| Ketring, AR | 1 |
1 trial(s) available for (ethylenedinitrilo)-tetramethylenephosphonic acid and Ache
| Article | Year |
|---|---|
Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases.
Topics: Bone and Bones; Bone Marrow; Bone Neoplasms; Chelating Agents; Humans; Organophosphorus Compounds; Pain; Palliative Care; Radioisotopes; Radionuclide Imaging; Radiotherapy Dosage; Samarium | 1994 |
2 other study(ies) available for (ethylenedinitrilo)-tetramethylenephosphonic acid and Ache
| Article | Year |
|---|---|
Analysis of urine samples from metastatic bone cancer patients administered 153Sm-EDTMP.
Topics: Bone Neoplasms; Chelating Agents; Chromatography, High Pressure Liquid; Humans; Organophosphorus Compounds; Pain; Radioisotopes; Samarium | 1993 |
153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals.
Topics: Animals; Bone Neoplasms; Dogs; Etidronic Acid; Humans; Kinetics; Organophosphorus Compounds; Pain; Rabbits; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Technetium Tc 99m Medronate; Tissue Distribution | 1987 |